{
    "2019-12-16": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Gains",
                        "Lags Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-20",
                "original_text": "Pacira's Exparel Spurs Growth, Exclusive Reliance a Concern",
                "features": {
                    "keywords": [
                        "Pacira",
                        "Exparel",
                        "Spurs Growth",
                        "Exclusive Reliance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-10",
                "original_text": "BeiGene Shares Tumble After Cancer Drug Challenge to Johnson & Johnson Misses Late-Stage Goals",
                "features": {
                    "keywords": [
                        "BeiGene",
                        "Shares Tumble",
                        "Cancer Drug",
                        "Challenge",
                        "Johnson & Johnson",
                        "Misses Goals"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}